137 related articles for article (PubMed ID: 2107019)
21. Topical mupirocin in the treatment of bacterial skin infections.
Rumsfield J; West DP; Aronson IK
Drug Intell Clin Pharm; 1986 Dec; 20(12):943-8. PubMed ID: 3102197
[TBL] [Abstract][Full Text] [Related]
22. Ozenoxacin 1% cream (Xepi) for impetigo.
Med Lett Drugs Ther; 2019 Apr; 61(1570):63-64. PubMed ID: 31169810
[No Abstract] [Full Text] [Related]
23. Topical antibiotics in dermatology.
Hirschmann JV
Arch Dermatol; 1988 Nov; 124(11):1691-700. PubMed ID: 2972259
[TBL] [Abstract][Full Text] [Related]
24. Mupirocin (2 percent) ointment in the treatment of primary and secondary skin infections.
Odom RB
Cutis; 1989 Jun; 43(6):599-601. PubMed ID: 2501071
[TBL] [Abstract][Full Text] [Related]
25. A bacteriologically controlled, randomized study comparing the efficacy of 2% mupirocin ointment (Bactroban) with oral erythromycin in the treatment of patients with impetigo.
McLinn S
J Am Acad Dermatol; 1990 May; 22(5 Pt 1):883-5. PubMed ID: 2112166
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of 2% mupirocin ointment in the treatment of primary and secondary skin infections--an open multicentre trial.
Bork K; Brauers J; Kresken M
Br J Clin Pract; 1989 Aug; 43(8):284-8. PubMed ID: 2516463
[TBL] [Abstract][Full Text] [Related]
27. A new topical antibacterial agent.
Watt B
Microbiol Sci; 1987 Nov; 4(11):336-7. PubMed ID: 3155275
[No Abstract] [Full Text] [Related]
28. Comparison of oral cephalexin, topical mupirocin and topical bacitracin for treatment of impetigo.
Bass JW; Chan DS; Creamer KM; Thompson MW; Malone FJ; Becker TM; Marks SN
Pediatr Infect Dis J; 1997 Jul; 16(7):708-10. PubMed ID: 9239775
[No Abstract] [Full Text] [Related]
29. Innovation and development in oral and topical antibiotics.
Crook SJ
Practitioner; 1986 Mar; 230(1413):249-56. PubMed ID: 3086858
[No Abstract] [Full Text] [Related]
30. Diagnosis and treatment of impetigo.
Cole C; Gazewood J
Am Fam Physician; 2007 Mar; 75(6):859-64. PubMed ID: 17390597
[TBL] [Abstract][Full Text] [Related]
31. Pseudomonic acid, a new antibiotic for topical therapy.
Wuite J; Davies BI; Go MJ; Lambers JC; Jackson D; Mellows G; Tasker TC
J Am Acad Dermatol; 1985 Jun; 12(6):1026-31. PubMed ID: 3924981
[TBL] [Abstract][Full Text] [Related]
32. Mupirocin ('pseudomonic acid')--a promising new topical antimicrobial agent.
Casewell MW; Hill RL
J Antimicrob Chemother; 1987 Jan; 19(1):1-5. PubMed ID: 3104272
[No Abstract] [Full Text] [Related]
33. Initial antibiotic treatment of bacterial meningitis in children. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
CMAJ; 1986 Nov; 135(10):1085-6. PubMed ID: 3768819
[No Abstract] [Full Text] [Related]
34. Pyoderma pathophysiology and management.
Leyden JJ
Arch Dermatol; 1988 May; 124(5):753-5. PubMed ID: 3129996
[TBL] [Abstract][Full Text] [Related]
35. Prevention of bacterial endocarditis. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
CMAJ; 1986 Jan; 134(1):28-9. PubMed ID: 3940602
[No Abstract] [Full Text] [Related]
36. Paediatric dermatology. Impetigo.
Hogan P
Aust Fam Physician; 1998 Aug; 27(8):735-6. PubMed ID: 9735496
[No Abstract] [Full Text] [Related]
37. A primer on topical antibiotics for the skin and eyes.
Noah S
J Drugs Dermatol; 2008 Apr; 7(4):409-15. PubMed ID: 18459527
[TBL] [Abstract][Full Text] [Related]
38. Mupirocin ointment indications.
Hudson I
Infect Control Hosp Epidemiol; 1990 Sep; 11(9):452. PubMed ID: 2121821
[No Abstract] [Full Text] [Related]
39. [Mupirocin: pharmacology and therapeutic indications].
Geoffray C; Chosidow O; Revuz J
Ann Dermatol Venereol; 1990; 117(10):753-7. PubMed ID: 2127340
[No Abstract] [Full Text] [Related]
40. Mupirocin in a polyethylene glycol carrier base.
Rode H; de Wet PM; Cywes S; Millar AJ
J Antimicrob Chemother; 1989 Jul; 24(1):78-9. PubMed ID: 2506166
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
